Answers are grounded in this paper and cite their sources.
Risk stratification in emergency department (ED) patients aged ≥85 years is challenging because advanced age, frailty, atypical presentation, and limited physiological reserve may alter the performance of prognostic tools developed in broader adult populations. The objective of this retrospective cohort study was to evaluate and compare the discriminative performance of the Modified Early Warning Score (MEWS) and Rapid Emergency Medicine Score (REMS) for 1-month mortality and secondary clinical outcomes in ED patients aged ≥85 years. A total of 1050 patients aged ≥85 years presenting to a tertiary ED between January 2023 and January 2025 were included in the study. MEWS and REMS were calculated from the initial clinical assessment. The primary outcome was 1-month mortality; secondary outcomes were hospitalization and intubation. Discrimination was evaluated using receiver operating characteristic analysis, and score-outcome associations were examined using univariable logistic regression. The mean age was 88.4±3.1 years, 62.8% were female, and 120 patients (11.4%) died within 1 month. Immobility, intubation, hospitalization, and chronic obstructive pulmonary disease were more frequent among non-survivors. For 1-month mortality, the area under the curve (AUC) was 0.939 [95% confidence interval (CI) 0.909-0.969] for MEWS and 0.946 (95% CI 0.918-0.974) for REMS; corresponding AUCs were 0.900 (95% CI 0.871-0.929) and 0.877 (95% CI 0.845-0.909) for hospitalization and 0.994 (95% CI 0.984-1.000) and 0.997 (95% CI 0.990-1.000) for intubation. In univariable models, each one-point increase in REMS and MEWS was associated with higher odds of 1-month mortality [odds ratio (OR) 2.39, 95% CI 2.05-2.78; and OR 2.43, 95% CI 2.12-2.78, respectively]. MEWS and REMS showed high discrimination for short-term outcomes in this oldest-old ED cohort. Their principal contribution in this setting is comparative risk discrimination within an age group that is underrepresented in validation studies, rather than demonstration that established prognostic scores are associated with adverse outcomes. REMS showed slightly higher mortality discrimination, whereas MEWS retained the advantage of bedside simplicity.
No takes yet. Share an insight, caveat, or question.
Özbilir et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: